home / stock / clsd / clsd news


CLSD News and Press, Clearside Biomedical Inc. From 09/15/25

Stock Information

Company Name: Clearside Biomedical Inc.
Stock Symbol: CLSD
Market: NASDAQ
Website: clearsidebio.com

Menu

Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...

CLSD - US Companies Moving the Markets, Morning edition
Mon, Sep 15, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States AtlasClear Holdings Inc. (ATCH) rose 159.0% to $1.01 on volume of 178,813,615 shares Direxion Daily TSLA Bull 2X Shares (TSLL) rose 10.7% to $18.845 on volume of 141,128,366 shares Hyperscale Data Inc. (GPUS) rose 48.5% to $0.5495 on vo...

CLSD - Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress

- Presentations Highlight the Versatility of Clearside’s SCS Microinjector ® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to be Featured in Presentation by Dr. Sobha Sivaprasad - ALPHARETTA, Ga.,...

CLSD - Expected earnings - Clearside Biomedical Inc.

Clearside Biomedical Inc. (CLSD) is expected to report $-0.12 for Q2 2025

CLSD - US Companies Moving the Markets, Evening edition
Wed, Jul 23, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) rose 32.6% to $0.0252 on volume of 883,797,424 shares Wang & Lee Group Inc. (WLGS) rose 87.2% to $0.132 on volume of 651,344,114 shares Opendoor Technologies Inc (OPEN) fell 20.5% to $2.29 on volume o...

CLSD - Biotech in Focus: Regulatory Wins, Strategic Moves, and Speculative Momentum

2025-07-23 12:06:03 ET DENVER, Colo., Jul 23, 2025 ( 247marketnews.com )- Biotech stocks are making headlines again, with catalysts ranging from major international approvals and global partnerships to strategic restructurings and high-stakes market reversals. Here’s a closer loo...

CLSD - US Companies Moving the Markets, Morning edition
Wed, Jul 23, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) rose 36.3% to $0.0259 on volume of 324,932,014 shares Wang & Lee Group Inc. (WLGS) rose 78.3% to $0.1257 on volume of 305,200,431 shares Mullen Automotive Inc. (MULN) rose 16.0% to $0.0905 on volume o...

CLSD - Clearside Biomedical Secures Canadian Approval for XIPERE as Suprachoroidal Treatment for Uveitic Macular Edema

2025-07-23 08:53:30 ET DENVER, Colo., Jul 23, 2025 ( 247marketnews.com )- Clearside Biomedical (NASDAQ:CLSD) reported that Health Canada approved XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use in the treatment of uveitic macular edema (UME) , marki...

CLSD - Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada

- XIPERE Now Approved for Use in Multiple Global Markets - - Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector ® - ALPHARETTA, Ga., July 23, 2025 (GLOBE NEWSWIRE) -- Cl...

CLSD - US Companies Moving the Markets, Evening edition
Fri, Jul 18, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 36.4% to $2.25 on volume of 547,098,005 shares Incannex Healthcare Inc. (IXHL) rose 64.8% to $0.61 on volume of 472,694,351 shares Bit Origin Limited (BTOG) rose 23.6% to $0.78 on volume of 357,677,...

CLSD - Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline

- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases - - CLS-AX Phase 3-Ready Asset with Global Investigator Support and FDA Alignment on Pivotal Trial Program in wet AMD - - Validated Delivery...

Previous 10 Next 10